Skip to main content
THERAGEN ETEX CO.,LTD. logo

THERAGEN ETEX CO.,LTD. — Investor Relations & Filings

Ticker · 066700 ISIN · KR7066700006 KO Manufacturing
Open in API
Filings indexed 193 across all filing types
Latest filing 2022-04-04 Board/Management Inform…
Country KR South Korea
Listing KO 066700

About THERAGEN ETEX CO.,LTD.

http://www.theragenetex.com/

THERAGEN ETEX CO.,LTD. is a biotechnology and pharmaceutical group focused on genome-based personalized and precision medicine. The company integrates advanced genomic analysis with pharmaceutical development and manufacturing. Its genomics division provides comprehensive genetic analysis services, leveraging pioneering achievements such as creating the world's first female and tiger genome maps and commercializing Asia's first individual genome analysis service. The pharmaceutical division develops and supplies medicines from its international GMP-certified facilities. The R&D pipeline focuses on incrementally modified drugs, orphan drugs, and novel anticancer therapies, including its proprietary drug candidate, Vactosertib, which is in clinical trials for various cancers.

Recent filings

Filing Released Lang Actions
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details changes to the board of directors, specifically the reappointment of an outside director. According to the filing definitions, announcements regarding changes in the company's board of directors or senior management fall under the 'MANG' category.
2022-04-04 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the voting outcomes for various agenda items (financial statement approval, director appointments, etc.) held on March 31, 2022. It explicitly lists the results of the shareholder votes, including which items were approved and which were rejected due to quorum issues. This aligns perfectly with the definition of a Declaration of Voting Results (DVA).
2022-03-31 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled 'Audit Report Submission' (감사보고서 제출) submitted to the Korea Exchange (KRX). It provides a summary of the audit opinion, key financial data (assets, liabilities, equity, profit/loss), and auditor information for the fiscal year. While it contains financial data, it is a standardized regulatory disclosure form used in the Korean market to announce the completion and submission of the audit report, rather than the full annual report (10-K) itself. Therefore, it is classified as an Audit Report/Information document. FY 2021
2022-03-23 Korean
사업보고서 (2021.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'Theragen Etex' (주식회사 테라젠이텍스) for the fiscal year ending December 31, 2021. It includes the independent auditor's report, financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and notes to the financial statements. This is a comprehensive audit document, not an annual report (10-K) or a simple announcement (RPA). FY 2021
2022-03-23 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Proxy Solicitation & Information Statement' (의결권대리행사권유참고서류) filed by Theragen Etex. It contains information regarding the upcoming Annual General Meeting (AGM), including the purpose of the meeting, voting procedures (electronic voting/proxy), and details about the company's financial status and management. While it contains financial data, the primary purpose of this specific filing is to solicit proxies from shareholders for the AGM, which aligns with the definition of a Proxy Solicitation & Information Statement.
2022-03-17 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for (주)테라젠이텍스. It contains the agenda for the Annual General Meeting (AGM), including voting items such as financial statement approval, director appointments, and remuneration limits. It also includes management information and proxy voting instructions. This document is the primary material provided to shareholders to inform them of the upcoming meeting and the matters to be voted upon, which fits the definition of Proxy Solicitation & Information Statement.
2022-03-15 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.